OmniAb, Inc. (OABI)
(Delayed Data from NSDQ)
$1.63 USD
+0.03 (1.88%)
Updated Oct 24, 2025 04:00 PM ET
After-Market: $1.62 -0.01 (-0.61%) 7:58 PM ET
2-Buy of 5 2
F Value D Growth C Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
OABI 1.63 +0.03(1.88%)
Will OABI be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for OABI based on the 1-3 month trading system that more than doubles the S&P 500.

Zacks News for OABI
Zevra Therapeutics (ZVRA) Surges 12.3%: Is This an Indication of Further Gains?
OmniAb, Inc. (OABI) Reports Q2 Loss, Lags Revenue Estimates
OABI: What are Zacks experts saying now?
Zacks Private Portfolio Services
OmniAb, Inc. (OABI) Reports Q1 Loss, Misses Revenue Estimates
OmniAb, Inc. (OABI) Reports Q4 Loss, Tops Revenue Estimates
Nektar Therapeutics (NKTR) Q4 Earnings Miss Estimates (Revised)
Other News for OABI
OABI forms 20 Day Moving Average Resistance on October 24
20 Day Moving Average Resistance appears for OABI after 3.03% move
Is OABI primed for downward momentum? Fell Below 20 Day Moving Average shows up after declining 0.6%
Is OABI building bullish momentum? 20 Day Moving Average Support shows up after sinking 4.05%
Crossed Above 50 Day Moving Average appears for OABI after 4.22% move